Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission

Few studies have demonstrated treatment strategies about the duration and cessation of medications in patients with Crohn’s disease (CD). We investigated factors affecting clinical relapse after infliximab (IFX) or azathioprine (AZA) withdrawal in pediatric patients with CD on combination therapy. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Tae Jong, Kim, Eun Sil, Kwon, Yiyoung, Kim, Seonwoo, Seo, Sang Won, Choe, Yon Ho, Kim, Mi Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752804/
https://www.ncbi.nlm.nih.gov/pubmed/35017546
http://dx.doi.org/10.1038/s41598-021-04304-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752804/
https://www.ncbi.nlm.nih.gov/pubmed/35017546
http://dx.doi.org/10.1038/s41598-021-04304-6

Ejemplares similares